Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 4 1

Status

Not yet recruiting 3Completed 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gynecologic 1Breast 1

Conditions

Sleep Initiation and Maintenance Disorders 1Ovarian Neoplasms 1Depression 1Breast Neoplasms 1Anxiety Disorders 1

Interventions

pembrolizumab 245Nivolumab 141Cisplatin 137Cyclophosphamide 134Paclitaxel 115Carboplatin 108Gemcitabine 98Radiotherapy 84Dexamethasone 83Docetaxel 77atezolizumab 69Ipilimumab 67Fluorouracil 61Doxorubicin 61Blood Specimen Collection 59Bevacizumab 59Rituximab 55fludarabine 54Etoposide 53Oxaliplatin 52Lenalidomide 50Surveys and Questionnaires 49Prednisone 47Standard of Care 45Magnetic Resonance Spectroscopy 45Radiosurgery 44Cetuximab 44lenvatinib 43Capecitabine 43durvalumab 42

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Esketamine × 1 year × Clear all
NCT06624878 2026-02-27

Esketamine for Prevention of Depression After Cytoreductive Surgery in Ovarian Cancer

Zhejiang Cancer Hospital

Phase NA Completed
568 enrolled
Gynecologic

Depression, Ovarian Neoplasms

NCT06530706 2025-09-16

Effect of Esketamine on Anxiety State in Patients Undergoing Abdominal Tumor Surgery

Zhejiang Cancer Hospital

Phase NA Completed
185 enrolled

Anxiety Disorders

NCT05732064 2025-07-31

Dexmedetomidine-esketamine Combined Nasal Administration and Perioperative Sleep Quality

Peking University First Hospital

Phase 4 Completed
180 enrolled
Breast

Breast Neoplasms, Sleep Initiation and Maintenance Disorders

Data powered by HemOnc (CC BY 4.0) Colophon âš¡